DatasetName,ENSA_S(106) ENSA_S(108) ENSA_S(109) ENSA_S(131) ENSA_S(132) ENSA_S(2) ENSA_S(3) ENSA_T(135),ENSA_S(43) ENSA_T(112) ENSA_T(115) ENSA_T(21) ENSA_T(99)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.6606700861035586,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.6154896740912557,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.6450200589088794,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.6278671522336927,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.6120922270381725,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.6729304585165494,0.4515291832279161
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.6295527075796326,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,0.6456288515883329,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.40715723400148285
WZ2023_Pu_010_30min,0.6293141664202604,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.6607075052195592,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.6655235518844124,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.6610852131711895,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.6602879360531148,0.4659499431228243
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,0.6006295852011838,
PG2020_Intensity 8h_C,0.6239054300928158,0.44815725316487975
AH2018_SILAC_MR_2_N,0.6838347313753913,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.643891162462973,0.44924469433187647
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.4677973922949398
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.6882046508137049,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.6800546400875532,
RB2022_2_PreSprint,0.6437938076303454,
ZX2022_CB treated Replicate 3,0.6279936005834204,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6332199553658145,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.6290500814901356,
KBE2022_Log2_Ex_34_U,0.6939851930626573,0.4761134728477184
WZ2023_Pu_005_10min,0.6331229324090076,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.6577860496867857,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.6294048000389416,
AH2018_SILAC_MR_2_X,0.6781443968412229,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,0.6273894701161147,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.6613989976986843,0.4397292615194802
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.7071074388083308,
EJN2021_3_Rest_Basal,0.6409269141295957,
CR2017_Ratio Replicate 1.3,0.6521483426170708,0.4207868350457947
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.6656451822053918,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.6613307864004568,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,0.6450133403778671,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.6974111479771907,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6302940151260592,
CK2022_11 40-1,0.6567584151059247,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.666415407555954,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.6399673191651779,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.631583171834248,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.6629179545376399,0.43561898298015744
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.647582603186544,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,0.6278913179569953,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.6159379124122896,
CK2022_1 200-1,0.641632376209789,
PG2020_Intensity Mock_10h_D,0.6288356362905017,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,0.6350838394634135,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.43767524005254116
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.623725615358942,0.48642006795899173
PG2020_Intensity 2h_C,0.6313553460518313,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.6253333162060408,
KBE2022_Log2_Ex_8_T,0.675615646076867,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.6552350042343315,
CK2022_3 40-1,0.6311025857448838,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.6329711116474653,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.6376449360359964,
EJN2021_5_Rest_Basal,0.6297753540385762,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.6595201502504059,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.6116584593130077,
RB2022_1_PostEndurance,0.6406879951706507,
CR2017_Ratio Replicate 3,0.5861520400431458,0.42152149458458144
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.6295539812377796,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.6573146846691131,
HS2024_8_I_T3,,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,0.6430150756987117,
WZ2023_Pu_010_20min,0.6275597981756412,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.6316959173366444,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.6171068575760139,
KS2014_Intensity N3,0.6457221961884239,
RB2022_4_RecoveryEndurance,0.6202646753493926,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.6563295989547694,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,0.6324153893950273,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.6373461060001111,0.4516783258156023
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.6373364880441919,0.47148057765702306
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.6658366916199938,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.6589510352807647,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.6831653015801197,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.687533055811813,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.6275641927528872,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.40813318064584364
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.6740528460447491,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.6641235216409509,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.596683307045615,
AH2018_SILAC_IT_3_X,0.662955321326436,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.6395448933561203,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.6401728956490556,
SR2019_HCC1954_Biol_repl_2,0.6356320269192066,
CK2022_14 40-1,0.6401809416932266,
RB2022_6_PreSprint,0.6257852519241527,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.6273463582521832,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.6507768085944792,
DL2023_control-1,,
AR2021_ALG 10 μM,0.6128562759338712,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.6616834526867784,
EJN2021_4_Rest_Ins,0.5915411610081711,
RN2012_H05,0.6397003594352514,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.6270400176047267,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.6712783938940032,
EJN2021_1_Rest_Ins,0.6308685782683675,
HH2022_Reporter intensity 3,0.6576722313416665,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.6465517451019523,
JW2021_After_3,,
GF2025_P8_Sph,0.65357854562481,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.6611056188340247,
CK2022_11 200-1,0.6670484272977741,
CK2022_12 200-1,0.663720454102705,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.6344055891397339,
WZ2023_Su_010_20min,0.6302216318271715,
AH2018_TMTMS2_2_N,0.6607317616076611,0.4649597259696545
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.6668141325425456,0.4442220461622554
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.6461964944868679,
AH2018_TMTMS3_Pool,0.6289114886139991,
KS2014_Intensity N4,0.64441712861419,0.4465997230175079
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.658649060789845,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.6797333973324291,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.6291076975478839,
AST2020_anti-CD3+PDL2.2,0.629225749937491,
PG2020_Intensity Mock_10h_A,0.6202512398516768,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.585780622251282,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.641760729028908,
GF2025_P1_Adh,0.657087047839392,
GF2025_P1_Sph,0.6441116403399773,
EJN2021_5_Ex_Basal,0.6375268338512086,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6330128280193399,
CF2017_EOC 1,0.6343140339153034,
CK2022_3 200-1,0.6402335538029698,
AH2018_LFQ_IT_3_C,0.648957948742701,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,0.6677863350135256,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,0.659619193146215,
CK2022_2 40-1,0.6312190167571905,
RB2022_1_PostSprint,0.6713886636113041,
CK2022_4 200-1,0.6422163494413248,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.6147306160475405,
AR2021_ALG 1 μM,0.633519029860659,0.4306671756245217
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.6376404880471932,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.6028431788092599,0.49059978330368337
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.6113619716925902,
CK2022_9 16-1,0.649779837081975,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.6574478924389822,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.6177118583051725,0.4352844456719846
CK2022_16 16-1,0.6384581606015848,
FS2019_db/db3,0.6108171543071534,
CK2022_15 40-1,0.6393670912627645,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6327019943050968,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.6684612686093426,0.44349727593689614
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.6663986420581396,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.6215734576867858,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.6665814820533676,
AH2018_LFQ_M_1_N,0.6665872972455624,0.42458732316735004
KBE2022_Log2_Ex_27_U,0.6632810973365785,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.656350809431065,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.6360003198580562,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.625991591275352,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.6451247739042852,
RN2012_L13,0.6166295615118504,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.6693618168119628,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.6589448168269102,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.6462020201797416,0.4591167093525074
HH2022_Reporter intensity 6,0.6301413589818892,
RB2022_2_RecoveryStrength,0.6108588111877099,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.6029837694416674,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.6710267611969541,0.46953918670580685
GF2025_P3_Adh,0.6308913240564202,
SR2019_JIMT1_Biol_repl_2,0.6232393413274384,
AH2018_TMTMS2_1_C,0.641235153123596,0.4665471299990459
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.6234612867072351,0.4690754183725633
KBE2022_Log2_Ex_19_U,0.6593468338369736,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,0.6665448755281224,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,0.6296636189654861,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),0.6587429386625294,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.5921132782236067,
RB2022_7_RecoverySprint,0.6061082479711026,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.6634156440854266,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.6401612077106454,0.42145026852265116
HH2022_Reporter intensity 1,0.6569119074334678,
HH2022_Reporter intensity 2,0.6572155713236458,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.4293726269582403
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.6737969311017575,0.4456228072679336
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.6308475887547017,0.47618769301567154
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.6819004778531614,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.6282441560212824,
KBE2022_Log2_Ex_9_U,0.6661087085893983,
AH2018_SILAC_M_3_N,0.659501431988246,
KBE2022_Log2_Ex_13_T,0.6768634313932044,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.6237469556489814,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.6411473907305592,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.6468933159661966,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.633720624697037,
RB2022_7_RecoveryEndurance,0.6112102275078176,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.6351164167462755,
TM2022_S2.12h.B,,
RN2012_L15,0.6410049231370689,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.6138018743568884,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.6629792900969792,0.4406235250444535
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.6500316815005577,0.42870900364226455
RB2022_1_PreSprint,0.6201728472849564,
HS2024_4_I_N1,,
CK2022_7 200-1,0.6456836087277833,
CK2022_5 200-1,0.6446963808406678,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,0.6611865970658066,
AH2018_LFQ_2_C,0.6529246196214145,
AH2018_SILAC_MR_1_X,0.6537146920188017,0.45611447584803455
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.6514639815939458,0.4326298485422864
AH2018_SILAC_3_C,0.6469518435582845,
EJN2021_5_Rest_Ins,0.5858675388277315,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.6186535820477556,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.632959838186019,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.6650393111805519,0.41367027110669136
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.621210730219332,0.44040321414966865
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.6724028662202731,
AH2018_SILAC_IT_2_N,0.667653824216524,
AH2018_SILAC_IT_1_X,0.6512521991664477,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.6347994608585702,
WZ2023_Pe_025_20min,0.6338895980479216,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.6705280668581461,0.42936220621439974
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.664463322382531,0.4639972332714611
RN2012_H06,0.6289436158259775,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.6287481254406699,
SR2019_HCC1419_Biol_repl_4,0.6165361226117057,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,0.6242046731523472,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5895330205809168,0.4330839504073475
WZ2023_Su_025_10min,0.6320380393312044,
AH2018_LFQ_IT_4_X,0.6655354480797689,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.631410306857458,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,0.5855810249897655,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,0.47465503845650314
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,0.6300098664349048,
KS2014_Intensity,0.6513426974068993,0.4555176097241381
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.6254053135141462,0.45405960113686683
LY2019_P7+,0.6345938735461133,
EP2017_Untreated R#1 normalized log2 ratio,,0.5226983520199772
RN2012_L10,,
PG2020_Intensity 4h_C,0.6322529576127667,
EP2017_Mitotic R#3 normalized log2 ratio,,0.4562750820009492
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.6690505783722693,0.4458540772171397
RB2022_8_PostStrength,0.6118140870762011,
AH2018_SILAC_IT_2_X,0.6680030549564626,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.6501354224694434,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.6698968257126912,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.6561564525245916,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.4466671282098054
GF2025_P9_Sph,0.5729379726674075,
CK2022_6 200-1,0.643233735428044,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.6190468135008431,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.6181044445887601,
EP2017_Untreated R#3 normalized log2 ratio,,0.45947595928228724
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.6465918862249671,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.6396921709988075,0.45962790536342035
RB2022_7_PostEndurance,0.6729498018078897,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.48407073198673134
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.6489273273204678,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.6681640967139968,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.6370171453414988,
FR2021_Intensity.M,,
RB2022_2_PostSprint,0.6634206583659162,
AH2018_SILAC_MR_3_N,0.669097407525963,0.45907215072725693
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.6289238288506789,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,0.6426717591183704,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.6623616955741465,
EP2017_Untreated R#3 log2 ratio,,0.46111202194070683
RB2022_2_PostStrength,0.6554172636215823,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.6129994458530186,0.4407937331290529
HS2024_8_PD_T2,,
FS2019_Ctr2,0.6565664660894128,
RB2022_6_PreEndurance,0.6324287708537861,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.6681872974906145,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.652777806483498,
CR2017_Ratio Replicate 2.3,0.6366887333708583,0.4812384792046599
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.6148591210524847,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.4344816429288848
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.6720372431022517,0.43787081081021445
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.6684721123865178,
CK2022_2 16-1,0.6209281788453638,
RAM2015_Log2 B,0.6288952060784481,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.6349783030920019,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.6368861857273194,
WZ2023_Su_025_30min,0.6310760818692306,
AH2018_LFQ_4_N,0.6675386652658004,
CR2017_Ratio Replicate 1.2,0.6334763748940978,0.41840876330697724
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.6647564307948618,
RB2022_7_PreEndurance,0.6253286398078098,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.6152250544467054,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.6254369665038795,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,0.6518227447223643,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.6297506546138246,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,0.6139149158478586,
KS2014_Intensity C5,0.6554150590753649,0.4578878064124967
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.6156711265540249,
RB2022_3_PostStrength,0.6833292588864599,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.6692753612114091,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.6295543954906759,0.454168871521529
AH2018_LFQ_2_X,0.6741121785481688,
PG2020_Intensity 2h_B,0.6263383415549593,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.6466742679380845,
KS2014_Intensity E15_3,0.6421954782227416,0.44728528739372103
GF2025_P3_Sph,0.6539609096051227,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.6449763650534168,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.6643195011247769,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.6497584492137307,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.6580471113769726,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.6538502492563742,0.4640383619166476
ZQ2022_N1,,
LY2019_P6-,0.6092930335451961,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.6192410574202767,
AH2018_LFQ_3_N,0.6666434092042309,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.6738456517706045,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.63371195197065,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.6324878219844494,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,0.6969815370575677,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.6293776364719965,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.6073422302032451,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.6416860781021679,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.6433604070579845,
RB2022_8_PreEndurance,0.6722077715573929,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.6340117982133107,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.6429209939066135,
EP2017_Pervanadate R#3 log2 ratio,,0.4684831155908582
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,0.6256496114227937,
AH2018_SILAC_MR_3_C,0.6660863581693787,0.411112818331752
AH2018_LFQ_M_4_C,0.6533840388049397,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.6133103514095791,
CK2022_6 40-1,0.6308599648585361,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.656033786493698,
LY2019_P3-,0.6324762267767221,0.4509593578417772
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.6469587955247195,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6342292932288671,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.63292147929145,
AST2020_Control.1,0.6284660339663914,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.6244137152976137,
FS2019_Ctr3,0.6492415781849724,
WZ2023_Pu_025_20min,0.6300074631390785,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.588115948502993,
RB2022_1_RecoveryStrength,0.6323711296074942,
SR2019_HCC1954_Biol_repl_4,0.6328114124724437,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6476813450958305,0.46341622266607646
RB2022_4_PreSprint,0.6364887972920191,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.6281567378989619,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.6459865076946162,
LY2019_P8+,0.6093726360435356,
RB2022_2_RecoveryEndurance,0.623793244697594,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.6708307813184398,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.6564231477613036,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.6827394002388012,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.676540917078488,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,0.6104647716320872,0.4506794596430045
AH2018_LFQ_IT_1_X,0.66565403625069,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.6323613174371072,
AST2020_Control.2,0.6286403949997059,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.6315487082233214,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.6611031143822703,
AH2018_TMTMS3_3_N,0.636073775740602,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.6476618703994647,0.4570529093197657
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.4561508678153742
KBE2022_Log2_Ex_36_T,0.6713916608354197,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6311629532306231,
KS2014_Intensity C2,0.6483380512032926,0.44655976163250627
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.6636324195324166,
CK2022_9 200-1,0.6670872081948443,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.6680949557376507,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.6636962820424216,0.44001200889716
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.6467346778862104,0.4720915345399298
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.6371199084859265,0.4552190206782166
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.5852082832685815,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.6663762560967849,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.524709367513065
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6321118319055471,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.6266606200288773,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.6430548991390678,0.3841512816106813
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.6339249277563519,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.6643349217656258,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.6233741555882113,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.667975031004696,0.4581201628993961
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.6263123483466643,0.4652463512844909
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.6313664503564692,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.628987880305767,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6328265008435296,
KBE2022_Log2_Ex_29_U,0.662756272671284,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.675569588161815,
AH2018_LFQ_IT_4_N,0.6594222188423317,
CK2022_15 200-1,0.6572049741232492,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.6965617522233025,0.47265578304228484
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5936119593203515,0.43705926895121133
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.6409490649834905,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6278263690879916,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.635873289300287,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.4740989723606327
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.677569134870705,0.4608734518024402
WZ2023_Pe_010_20min,0.6300713527605037,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.5976779003010282,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),0.6478746318034093,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.645260416494847,0.4524092188581161
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.6470021342258457,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.6489554659233584,
AH2018_SILAC_M_2_X,0.6658281388498033,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.6762651386317224,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.6334142329827231,
PG2020_Intensity 6h_C,0.6254785463643969,0.45247291946992174
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.6684639207067296,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.6510651295083888,0.46548204939699767
CK2022_15 16-1,0.6404562691882908,
CK2022_3 16-1,0.6172616522080526,
LY2019_P4-,0.6234765198756135,0.46886202374749164
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.6364973476440517,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.62109819678114,
CK2022_10 16-1,0.6489380637145905,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.65226089867535,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.44474290848372766
EJN2021_2_Ex_Basal,0.6318387403927933,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.6463694596044472,
CF2017_EOC 2,0.6338557336611659,
RB2022_6_PostEndurance,0.6534962504072466,
AH2018_SILAC_1_N,0.656336403420809,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,0.6125841860162642,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.6155240071461815,
ZX2022_CB treated Replicate 1,0.6256937292170324,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.6569559380499396,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,0.6228741550417355,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6653255631442465,0.4672842822132214
AR2021_L41 1 μM,0.6495408657515912,0.42323932297002226
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.6572154708904878,0.46844465029970356
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.6216814668635068,
KS2014_Intensity C4,0.6543222123272024,0.4575786230791339
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.6808043362036887,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.6540700762927999,0.40783059396268107
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.6488533448967232,
AH2018_SILAC_IT_3_C,0.6568803657699973,
WZ2023_Pu_025_10min,0.6356698527570891,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.6273185704919819,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.6317152789443614,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.661090487204979,
KS2014_Intensity C6,0.6491110702172935,0.44569554995980665
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.6481786484294753,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.6267667223731923,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.6382070053201776,
AH2018_SILAC_IT_2_C,0.6659956437535073,
CK2022_5 40-1,0.6315407881322536,
AH2018_LFQ_3_X,0.6775028906274129,
UK2020_UA_3,,
LY2019_P7-,0.6437067109040217,
GF2025_P5_Adh,0.6584680535181404,
RB2022_1_PostStrength,0.6516937198121635,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,0.6349184295346276,
CR2017_Ratio Replicate 2.2,0.621690520541843,0.41304426803464944
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.6491071958293197,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.6088560022426496,0.47053448027399175
PG2020_Intensity CT_B,0.6255577648626154,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.653568114564834,0.4586863119987493
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),0.6417383295563117,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,0.6280871572198529,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.6515620882165106,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.6774267872499504,0.4220759048302044
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.6326200604342859,
RB2022_2_PreEndurance,0.6144857171649142,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.6562070869701288,0.44061116870785727
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.6398798506025051,
AST2020_anti-CD3+PDL2,0.6292820780775379,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.6625576049052139,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.6687123044307457,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),0.6662888461873939,
EP2017_Mitotic R#2 log2 ratio,,0.4359055861111095
AH2018_TMTMS2_1_X,0.6675303197133939,0.47045861599178573
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.6277875758137118,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,0.6202288988300182,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.6657380915894517,
PG2020_Intensity 10h_B,0.6368437740555213,
AH2018_TMTMS3_1_X,0.6188016306521478,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.6468394798152463,
SR2019_HCC1419_Biol_repl_3,0.6213802966918547,
KBE2022_Log2_Ex_14_T,0.6678521040564593,
EP2017_Untreated R#2 normalized log2 ratio,,0.4280623585213742
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.6716368039373257,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,0.48471113401793886
AS2011_Ratio H/L Normalized RNAi_2_1,,
